gliosarcoma
Showing NaN - NaN of 10
Glioblastoma, Gliosarcoma Trial in Miami, Atlanta, Baltimore (radiation, procedure, drug)
Active, not recruiting
- Glioblastoma
- Gliosarcoma
- Dose-Escalated Radiation Therapy
- +2 more
-
Miami, Florida
- +2 more
Feb 16, 2022
Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Diffuse Intrinsic Pontine Glioma Trial in Australia, Canada, United States
Completed
- Anaplastic Astrocytoma
- +3 more
- 3-Dimensional Conformal Radiation Therapy
- +3 more
-
Birmingham, Alabama
- +179 more
Oct 5, 2021
Recurrent Glioblastoma, Recurrent Adult Brain Tumor, Gliosarcoma Trial in United States (HSPPC-96, bevacizumab)
Active, not recruiting
- Recurrent Glioblastoma
- +2 more
- HSPPC-96
- bevacizumab
-
Anchorage, Alaska
- +416 more
Aug 16, 2021
Glioblastoma, Glioma, Gliosarcoma Trial in United States (Bevacizumab, TTFields Therapy)
Terminated
- Glioblastoma
- +2 more
- Bevacizumab
- TTFields Therapy
-
La Jolla, California
- +10 more
May 12, 2021
Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Bevacizumab)
Completed
- Glioblastoma Multiforme
- +3 more
- Indoximod
- +3 more
-
Castro Valley, California
- +16 more
May 26, 2020
Glioblastoma, Gliosarcoma, Supratentorial Glioblastoma Trial in Canada, Israel, United States (radiation, biological, other,
Completed
- Glioblastoma
- +2 more
- 3-Dimensional Conformal Radiation Therapy
- +6 more
-
Mobile, Alabama
- +329 more
Jul 22, 2019
Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in Worldwide (Rindopepimut (CDX-110) with GM-CSF,
Completed
- Glioblastoma
- +4 more
- Rindopepimut (CDX-110) with GM-CSF
- +2 more
-
Birmingham, Alabama
- +222 more
Jan 11, 2018
Malignant Glioma, Glioblastoma Multiforme, GBM Trial in United States (131-I-TM-601, 131I-TM601)
Unknown status
- Malignant Glioma
- +5 more
-
Birmingham, Alabama
- +18 more
Apr 1, 2009